Patents by Inventor Valentin Pavlov

Valentin Pavlov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210378727
    Abstract: A portable cryogenic applicator includes a vessel for liquid nitrogen to deliver liquid nitrogen for treatment of skin surfaces using the rotating roller from porous biocompatible material. The cryogenic applicator includes a capillary U-bend to prevent spontaneous discharge of liquid nitrogen through the capillary system to the roller during filling or refilling the cryogenic applicator with liquid nitrogen. The cryogenic applicator also includes a vacuum valve that produce an insulating vacuum environment in a vacuum cavity to prevent heat transfer between the vessel for liquid nitrogen and a vacuum casing, which allows the external surface of the cryogenic applicator to be maintained at ambient temperature. The cryogenic applicator may include a control valve for regulating and maintaining the working pressure in the vessel for liquid nitrogen sufficient to deliver liquid nitrogen through the capillary system and the porous roller body to the surface skin of a patient.
    Type: Application
    Filed: October 7, 2019
    Publication date: December 9, 2021
    Applicant: Vitatrop Inc.
    Inventors: Olga Goulko, Khasanbi Erganokov, Valentin Pavlov
  • Publication number: 20080070901
    Abstract: A method of treating a subject with a cytokine-mediated inflammatory disorder comprising administering to the subject an effective amount of a pharmaceutically acceptable cholinesterase inhibitor, provided that the inhibitor is not galantamine.
    Type: Application
    Filed: August 14, 2007
    Publication date: March 20, 2008
    Inventors: Kevin Tracey, Valentin Pavlov
  • Publication number: 20050222123
    Abstract: A method of treating a subject with a cytokine-mediated inflammatory disorder comprising administering to the subject an effective amount of a pharmaceutically acceptable cholinesterase inhibitor, provided that the inhibitor is not galantamine.
    Type: Application
    Filed: January 27, 2005
    Publication date: October 6, 2005
    Applicant: North Shore-Long Island Jewish Research Institute
    Inventors: Kevin Tracey, Valentin Pavlov